Breaking News
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
Solving the gut inflammation puzzle

Solving the gut inflammation puzzle

image_pdfDownload PDFimage_print

Inflammatory bowel disease (IBD), an umbrella term for a number of gut disorders—including ulcerative colitis and Crohn’s disease—remains a clinical challenge. Current treatments don’t work for all patients, and many stop working over time. But despite their different responses to treatment, all IBD patients share a commonality: intestinal inflammation. Better understanding what drives gut inflammation is therefore important for finding medicines that work effectively and consistently for patients.

Now, researchers from Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with scientists at Technion—Israel Institute of Technology, have identified a protein that drives intestinal inflammation. This finding highlights new opportunities for creating targeted therapeutics. The study published today in Cell Reports.

“Scientists have long known that proteins associated with inflammation can also be linked with IBD. In fact, a U.S. Food and Drug Administation (FDA)-approved clinical diagnosis for IBD relies on some of these proteins. Yet, the cause for the intestinal inflammation remained unknown,” says Yu Fujita, M.D., Ph.D., first author of the paper and a postdoctoral fellow in the laboratory of Ze’ev Ronai, Ph.D., a professor at SBP’s NCI-designated Cancer Center. “Our study has found this mystery player to be a protein that is part of the cell’s protein homeostasis system, RNF5.”

First, the reseachers created mice that lacked the RNF5 gene. These mice displayed limited symptoms of intestinal inflammation, but when exposed to an inflammation-inducing agent, the mice developed severe IBD, indicating RNF5 plays a critical role in this disease. Biochemical analysis for proteins that may be regulated by RNF5 identified S100A8, a protein that was previously linked to a number of inflammatory disorders and commonly used for detection of IBD.

“Once we identified S100A8 as a protein regulated by RNF5 in the cells that line the gut, we realized we may have identified an important player in IBD,” adds Ronai.

Indeed, higher levels of S100A8 were found in the cells that line the gut, and also in the blood of mice that lacked RNF5, making it a suspect in the etiology of intestinal inflammation. When S100A8 was inactivated in the blood using neutralizing antibodies, the severe IBD symptoms were halted. This pointed to its role in driving the disease and as a potential target for IBD therapeutics.

“Our findings indicate that RNF5 is the lock that keeps a key inflammatory protein under control. Once this lock is broken, ‘Pandora’s box’ is opened, and S100A8 is released to cause inflammation,” says Ronai.

To confirm these findings in a human disease setting, the scientists tested intestinal tissue samples from 19 patients with ulcerative colitis and compared these to samples from healthy people. Disease severity was linked to lower levels of RNF5 and higher levels of S100A8—mirroring symptoms in the mice that lacked RNF5.

“People with IBD are in urgent need of new treatments,” adds Ronai. “These results support pursuit of therapeutic reagents that neutralize S100A8, or a RNF5 modulator. RNF5 also appears to be a potential predictor of disease severity, and could be used as a diagnostic marker.”

William Jeffery Sandborn, M.D., director of the Inflammatory Bowel Disease Center at UC San Diego Health, who was unaffiliated with the study, comments, “Nearly every day I work with IBD patients who are struggling to keep their disease under control. Better treatments that work for more patients are urgently needed. Although early, this study points to several promising targets that could lead to more personalized medicines or new diagnostics for IBD, a subject for future independent investigations.”

Avoiding unnecessary treatment

TNF inhibitors, which stop inflammation, are a common IBD treatment. However, this treatment doesn’t work for all patients. Predicting who will benefit from TNF inhibitors is important, as the medicines have serious side effects and should only be taken if necessary.

To see if there was a link between RNF5 and response to TNF therapy, the scientists assessed the level of RNF5 and S100A8 in patients that either responded or did not respond to TNF treatment. They found the samples from the non-responders had low levels of RNF5.

“This finding indicates RNF5 could help predict which IBD patients will respond to anti-TNF therapy,” says Ronai. “Measuring RNF5 might be a useful biomarker that helps IBD patients and doctors avoid unneccesary treatments.”


Explore further:
Researchers identify control mechanism for glutamine uptake in breast cancer cells

More information:
Cell Reports (2018). DOI: 10.1016/j.celrep.2018.08.057

Journal reference:
Cell Reports

Provided by:
Sanford Burnham Prebys Medical Discovery Institute

Tagged with:

About author

Related Articles